Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANI PHARMACEUTICALS INCANIP · Entity 4638 | Director | May 21, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANI PHARMACEUTICALS INC
Report date May 21, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,878 |
Ending reported balance
After 2026-06-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-21 · Grant · Acquired 4,357 · Balance 40,878 F1: Represents a restricted stock award that will vest in full on May 21, 2027. Row 2 · 2026-06-08 · Sale · Disposed 2,000 · Balance 38,878 F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock award that will vest in full on May 21, 2027.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2026 Filed Jun 11, 2026 01:06 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,000 | $80.88 | $161,760.00 |
DisclosureSEC source: 0001272247-26-000004 · wk-form4_1781140013.xml · nonDerivative · entry 2 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,878 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2026. Read SEC document |
| May 21, 2026 Filed Jun 11, 2026 01:06 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 4,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001272247-26-000004 · wk-form4_1781140013.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,878 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2027. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 21:38 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 19,341 | $85.93 | $1,661,972.13 |
DisclosureSEC source: 0001272247-25-000005 · wk-form4_1755207514.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,521 F1 · price: The shares were sold in multiple trades at prices ranging from $84.50 to $87.16. The price reported above reflects the weighted average sales price. Read SEC document |
| May 22, 2025 Filed May 27, 2025 22:21 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 4,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001272247-25-000003 · wk-form4_1748384492.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,862 F1 · kind: Represents a restricted stock award that will vest in full on May 22, 2026. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:45 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 4,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001272247-24-000003 · wk-form4_1716507934.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,526 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2025. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:30 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 6,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064140 · tm2316872-1_4seq1.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,116 F1 · kind: Represents a restricted stock award that will vest in full on May 23, 2024. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:31 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 10,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004401 · form4-04292022_030452.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,251 F1 · kind: Represents a restricted stock award that will vest in full on April 27, 2023. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 21:17 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | PurchaseCommon Stock | 2,500 | $39.38 | $98,450.00 |
DisclosureSEC source: 0001415889-21-005743 · form4-12072021_011229.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,202 Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:37 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 9,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001655 · form4-03252021_010300.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,702 F1 · kind: Represents a restricted stock award that will vest in full on March 23, 2022. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 20:34 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 7,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-046398 · tm2015775d7_form4.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,410 F1 · kind: The restricted stock vests on April 10, 2021. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 23:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | PurchaseCommon Stock | 3,000 | $45.05 | $135,150.00 |
DisclosureSEC source: 0001104659-20-029791 · tm2011887d1_form4.xml · nonDerivative · entry 2 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,291 F2 · price: The shares were acquired in multiple trades at prices ranging from $44.88 to $45.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 23:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | PurchaseCommon Stock | 2,000 | $45.18 | $90,360.00 |
DisclosureSEC source: 0001104659-20-029791 · tm2011887d1_form4.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,291 F1 · price: The shares were acquired in multiple trades at prices ranging from $45.1012 to $45.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 15, 2019 Filed May 15, 2019 20:32 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | PurchaseCommon Stock | 2,500 | $69.30 | $173,240.00 |
DisclosureSEC source: 0001144204-19-026615 · tv521741_form4.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,291 F1 · price: The shares were acquired in multiple trades at prices ranging from $69.09 to $69.3066. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 2,409 | $0.00 Strike: $66.39 | $0.00 |
DisclosureSEC source: 0001144204-19-017408 · tv517658_4.xml · derivative · entry 2 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,409 Underlying: Common Stock · 2,409 shares Expires 2029-03-27 F1 · security: The restricted stock and stock options vest on March 28, 2020. F1 · derivative.exercise_date: The restricted stock and stock options vest on March 28, 2020. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 1,991 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-017408 · tv517658_4.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,791 F1 · security: The restricted stock and stock options vest on March 28, 2020. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 20:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 2,225 | $0.00 Strike: $65.86 | $0.00 |
DisclosureSEC source: 0001144204-18-033529 · tv496174_4.xml · derivative · entry 2 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,225 Underlying: Common Stock · 2,225 shares Expires 2028-06-05 F1 · security: The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020. F1 · derivative.exercise_date: The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 20:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-033529 · tv496174_4.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 F1 · security: The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.